STAMFORD, Conn., Jan. 23, 2014 /PRNewswire/ -- ADENOFLEX® is a post-training supplement produced by GAT. The product was tested on experienced athletes in a double-blind, placebo-controlled clinical study conducted by an independent research facility. An abstract of the study was recently published in the Journal of the International Society of Sports Nutrition.
Link to study abstract: http://www.jissn.com/content/pdf/1550-2783-10-S1-P10.pdf
GAT President & CEO Charles Moser comments, "We continue to receive positive reviews from users of ADENOFLEX. They report that it gives them bigger, longer-lasting pumps that quickly lead to greater gains in muscle mass and performance. The ADENOFLEX clinical study provides evidence to support these observations. Importantly, we used experienced athletes in our study. Subjects had 2 to 10 years of resistance exercise experience. This demonstrates the potency of the product."
The ADENOFLEX clinical study is the first of its kind to have been conducted on a post-training supplement. The results provide evidence that ADENOFLEX produces measurable increases in muscular endurance and training volume after only 2 weeks of use. In turn, this allows athletes to push heavier loads for more reps --a pre-requisite for gaining muscle as quickly as possible.
Moser explains, "ADENOFLEX is the perfect companion to our clinically studied pre-training formula, NITRAFLEX®. Athletes can stack these products to help them smash through training plateaus and promote more rapid increases in muscle mass, strength, stamina, endurance, and testosterone."
GAT designs, studies and produces physique and performance enhancing dietary supplements for athletes and workout enthusiasts of all kinds. Its product portfolio includes clinically studied NITRAFLEX® and ADENOFLEX®, along with MUSCLE MARTINI®, SUPERTEIN®, TESTROL®, JETFUEL® weight-loss products, and many more. GAT products are available in over 50 countries and 10,000 brick-and-mortar and online retailers.